OneSource Specialty Pharma Limited (BOM:544292)
1,652.60
+60.85 (3.82%)
At close: May 13, 2025
BOM:544292 Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 |
---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 |
Cash & Equivalents | 3,009 | 64.72 | 49.74 |
Short-Term Investments | 88.83 | 157.92 | 45 |
Cash & Short-Term Investments | 3,098 | 222.64 | 94.74 |
Cash Growth | 1291.38% | 135.00% | - |
Accounts Receivable | 4,166 | 552.39 | 38.22 |
Other Receivables | - | 50 | - |
Receivables | 4,166 | 602.39 | 38.22 |
Inventory | 1,581 | 112.31 | 1,332 |
Prepaid Expenses | - | 31.13 | 10.82 |
Other Current Assets | 2,017 | 795.34 | 808.69 |
Total Current Assets | 10,862 | 1,764 | 2,284 |
Property, Plant & Equipment | 9,577 | 7,252 | 13,581 |
Long-Term Investments | 69.06 | 37.91 | - |
Goodwill | 38,275 | - | - |
Other Intangible Assets | 15,507 | 3,254 | 3,377 |
Long-Term Accounts Receivable | 562.39 | - | - |
Other Long-Term Assets | 649.86 | 778.28 | 846.08 |
Total Assets | 75,502 | 13,086 | 20,088 |
Accounts Payable | 1,755 | 810.23 | 948.2 |
Accrued Expenses | 122.26 | 290.59 | 142.96 |
Short-Term Debt | - | - | 1,939 |
Current Portion of Long-Term Debt | 5,523 | 2,906 | 3,079 |
Current Portion of Leases | 76.56 | 6.87 | 64.14 |
Current Income Taxes Payable | 117.24 | - | - |
Current Unearned Revenue | - | 59.55 | 59.55 |
Other Current Liabilities | 3,542 | 2,233 | 2,419 |
Total Current Liabilities | 11,136 | 6,306 | 8,652 |
Long-Term Debt | 2,193 | 2,716 | 3,349 |
Long-Term Leases | 1,632 | 83.22 | 211.15 |
Long-Term Deferred Tax Liabilities | 1,552 | - | - |
Other Long-Term Liabilities | 25.62 | - | - |
Total Liabilities | 16,697 | 9,129 | 12,234 |
Common Stock | 114.43 | 40.1 | 40.1 |
Additional Paid-In Capital | - | 22,040 | 22,040 |
Retained Earnings | - | -18,224 | -14,308 |
Comprehensive Income & Other | 58,691 | 101.83 | 82.33 |
Shareholders' Equity | 58,806 | 3,957 | 7,855 |
Total Liabilities & Equity | 75,502 | 13,086 | 20,088 |
Total Debt | 9,424 | 5,712 | 8,642 |
Net Cash (Debt) | -6,327 | -5,489 | -8,547 |
Net Cash Per Share | -57.38 | -132.12 | -214.66 |
Filing Date Shares Outstanding | 114.4 | 41.55 | 39.82 |
Total Common Shares Outstanding | 114.4 | 41.55 | 39.82 |
Working Capital | -273.82 | -4,542 | -6,368 |
Book Value Per Share | 514.02 | 95.25 | 197.26 |
Tangible Book Value | 5,024 | 702.67 | 4,477 |
Tangible Book Value Per Share | 43.91 | 16.91 | 112.45 |
Machinery | - | 7,921 | 12,334 |
Construction In Progress | - | 427.35 | 1,912 |
Leasehold Improvements | - | 1,212 | 1,441 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.